IS4510A - Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki - Google Patents

Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki

Info

Publication number
IS4510A
IS4510A IS4510A IS4510A IS4510A IS 4510 A IS4510 A IS 4510A IS 4510 A IS4510 A IS 4510A IS 4510 A IS4510 A IS 4510A IS 4510 A IS4510 A IS 4510A
Authority
IS
Iceland
Prior art keywords
analogues
diabetes
peptide
diagnosis
treatment
Prior art date
Application number
IS4510A
Other languages
English (en)
Other versions
IS1966B (is
Inventor
R. Cohen Irun
Elias Dana
Fridkin Matityahu
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4510(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of IS4510A publication Critical patent/IS4510A/is
Publication of IS1966B publication Critical patent/IS1966B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IS4510A 1994-12-21 1997-06-19 Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki IS1966B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
PCT/US1995/016596 WO1996019236A1 (en) 1994-12-21 1995-12-20 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES

Publications (2)

Publication Number Publication Date
IS4510A true IS4510A (is) 1997-06-19
IS1966B IS1966B (is) 2004-12-15

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4510A IS1966B (is) 1994-12-21 1997-06-19 Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki

Country Status (31)

Country Link
EP (1) EP0820303B1 (is)
JP (2) JP3420245B2 (is)
KR (1) KR100400480B1 (is)
CN (1) CN1233417C (is)
AR (1) AR002949A1 (is)
AT (1) ATE242005T1 (is)
AU (1) AU707835B2 (is)
BR (1) BR9510102A (is)
CA (1) CA2208274C (is)
CZ (1) CZ293784B6 (is)
DE (2) DE820303T1 (is)
DK (1) DK0820303T3 (is)
ES (1) ES2201137T3 (is)
FI (1) FI118373B (is)
HR (1) HRP950612B1 (is)
HU (1) HU224160B1 (is)
IL (1) IL116499A0 (is)
IS (1) IS1966B (is)
MX (1) MX9704738A (is)
NO (1) NO317350B1 (is)
NZ (1) NZ301440A (is)
PL (1) PL184145B1 (is)
PT (1) PT820303E (is)
RO (1) RO116777B1 (is)
RS (1) RS49517B (is)
SI (1) SI0820303T1 (is)
TR (1) TR199501630A2 (is)
TW (1) TW496872B (is)
UA (1) UA42040C2 (is)
UY (1) UY24130A1 (is)
WO (1) WO1996019236A1 (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
EP0914614B1 (en) * 1996-05-14 2003-09-03 Winnacker, Ernst-Ludwig, Prof. CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
EP2157101B1 (en) 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP peptides and analogs for modulation of immune responses via antigen presenting cells
EP1718158B1 (en) * 2004-01-28 2014-07-02 Andromeda Bio Tech Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
EP1835933A4 (en) * 2005-01-04 2015-01-07 Yeda Res & Dev HSP60, PEPTIDES HSP60 AND T-CELL VACCINES FOR IMMUNOMODULATION
EP1858545A2 (en) 2005-03-04 2007-11-28 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
JP2008545712A (ja) 2005-05-25 2008-12-18 キュアーディーエム、インク． ペプチド、その誘導体並びに類似体、及びそれらを使用する方法
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
WO2008064306A2 (en) 2006-11-22 2008-05-29 Curedm, Inc. Methods and compositions relating to islet cell neogenesis
MY165889A (en) 2007-08-30 2018-05-18 Curedm Group Holdings Llc Compositions and methods of using proislet peptides and analogs thereof
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
CA2864655A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
EP2819689A1 (en) 2012-03-01 2015-01-07 Yeda Research and Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
NO972849D0 (no) 1997-06-19
NZ301440A (en) 2000-01-28
DK0820303T3 (da) 2003-10-06
KR100400480B1 (ko) 2003-12-31
TR199501630A2 (tr) 1996-07-21
JP3420245B2 (ja) 2003-06-23
TW496872B (en) 2002-08-01
SI0820303T1 (en) 2003-10-31
PL184145B1 (pl) 2002-09-30
CA2208274A1 (en) 1996-06-27
RO116777B1 (ro) 2001-06-29
BR9510102A (pt) 1997-11-25
JP2004026797A (ja) 2004-01-29
CZ293784B6 (cs) 2004-07-14
ATE242005T1 (de) 2003-06-15
CN1175214A (zh) 1998-03-04
FI972669A0 (fi) 1997-06-19
MX9704738A (es) 1997-10-31
HUT78092A (hu) 1999-09-28
HRP950612A2 (en) 1997-10-31
DE69531004T2 (de) 2004-02-05
WO1996019236A1 (en) 1996-06-27
DE820303T1 (de) 1999-05-20
CN1233417C (zh) 2005-12-28
HU224160B1 (hu) 2005-06-28
IS1966B (is) 2004-12-15
FI972669A (fi) 1997-08-15
JPH10511649A (ja) 1998-11-10
RS49517B (sr) 2006-10-27
IL116499A0 (en) 1996-03-31
PL321091A1 (en) 1997-11-24
YU78795A (sh) 1998-05-15
AU707835B2 (en) 1999-07-22
CA2208274C (en) 2005-12-06
AU4686696A (en) 1996-07-10
PT820303E (pt) 2003-10-31
DE69531004D1 (de) 2003-07-10
AR002949A1 (es) 1998-05-27
JP3554319B2 (ja) 2004-08-18
UY24130A1 (es) 1996-06-11
CZ190897A3 (en) 1997-11-12
EP0820303B1 (en) 2003-06-04
FI118373B (fi) 2007-10-31
NO317350B1 (no) 2004-10-18
EP0820303A4 (is) 1998-03-11
ES2201137T3 (es) 2004-03-16
UA42040C2 (uk) 2001-10-15
HRP950612B1 (en) 2003-12-31
NO972849L (no) 1997-08-13
EP0820303A1 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
IS1966B (is) Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
NO20063000L (no) Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav.
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
NO964548D0 (no) Substituerte sulfonamider som selektive 3 agonister for behandling av diabetes og fedme
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DE69032679D1 (de) Threo (2R, 3S)-3-amino-2-hydroxypentansäure und threo (2R,3S)-3-(p-methoxy-benzyloxycarbonyl/FMOC) amino-2-hydroxy-pentansäure
ATE220542T1 (de) Zweiteilige kapsel zur aufnahme von pharmazeutischen zubereitungen für pulverinhalatoren
NL300432I2 (en) Pharmaceutical composition comprising pioglitazoneand glimepiride for use in treatment of diabetes.
IL131010A (en) Aryl sulfonamides and analogues thereof, processes for their preparation and pharmaceutical compositions comprising them in the treatment of neurodegenerative diseases
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
DE68903516D1 (de) Mittel zur senkung des blutdrucks.
ZA953336B (en) Substituted sulfonamides as selective B3 agonists for the treatment of diabetes and obesity
DK0771788T3 (da) Substituerede sulfonimidamider, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnostikum og
NO880179D0 (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse.
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
DE69821660D1 (de) Fungizide Mischung, enthaltend ein N-Acetylbenzamid und Folpet
DK1222921T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
DE3860754D1 (de) Blutdruckmonitor und dafuer verwendeter pneumatischer verbinder.
DK1100775T3 (da) 2,5-Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til fremstilling deraf, anvendelse deraf og farmaceutiske præparater indeholdende disse
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
ZA9711270B (en) Precursory forms and new analogues of camptothecin, the processes for their preparation, their medical application and the pharmaceutical substances that contain them.
ZA9510828B (en) Peptide p277 analogs and phamarceutical compositions comprising them for treatment or diagnosis of diabetes
GB9615710D0 (en) Pharmaceutical preparations for the treatment of sarcocystosis
DK1009767T3 (da) Humant defensin Def-X, gen og cDNA, præparat indeholdende disse og anvendelser til diagnose og behandling